Librando, Concepcion T.

HRN: 03 52 33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/12/2025
06/19/2025
IV
4.5g Now Then 2.25g
Q12
CAP MR
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines